Invuity’s patented Intelligent Photonics® devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
SAN FRANCISCO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to attend the following upcoming investor conferences: The Stifel Healthcare Conference 2017 on Wednesday, November 15, 2017 at 8:45 a.m. Eastern Time in New York. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website ...Read More
Full Launch of PhotonBlade(R) Completed SAN FRANCISCO, CA -- (Marketwired) -- 11/07/17 -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on minimal access surgery, today reported financial results for the quarter ended September 30, 2017. Q3 2017 Highlights Revenue grew 13% to $9.6 million compared to revenue of $8.5 million in the third quarter of 2016. Disposable revenue grew 17% to $7.5 million compared to $6.4 million in the third quarter of 2016. Approximately 845 hospitals purchased Invuity devices in the third quarter of 2017, up from approximately 700 hospitals in the third quarter of 2016. Ph...Read More
SAN FRANCISCO, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2017 third quarter financial results after the market closes on Tuesday, November 7, 2017. In conjunction with the release, the Company will host a conference call with the investment community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Tuesday, November 7, 2017, to discuss the financial results and other business developments. Interested parties may access the live call via telephone by dialing 1-877-556-8638 (U.S.) or 1-615-247-0174 (International), Conference ID: 3597539. To listen to t...Read More
“Invuity’s Intelligent Photonics technology significantly improves the quality of illumination and enables me to better identify and visualize even in and around neural elements of the spine. I believe the technology has helped me be even more precise in my work.”
“Invuity’s illumination technology enables me to do what I do when performing nipple sparing mastectomies and oncoplastic breast conservation procedures. It makes all the difference.”
White Plains, NY
“Invuity’s Intelligent Photonics Technology enables me to do what I do when performing nipple sparing mastectomies and oncoplastic breast conservation procedures. It makes all the difference.”
Principal Investigator and Chair of the Nipple Sparing Mastectomy Registry for the American Society of Breast Surgeons